Cargando…
Pharmacologic Therapy for COVID-19 Infection
The COVID-19 pandemic has focused attention on issues of epidemiology, public health, and vaccine design. I submit that attention to COVID-19 pharmacologic therapy needs similar emphasis, including identifying any existing medications that can be repurposed to treat COVID-19 patients.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169637/ https://www.ncbi.nlm.nih.gov/pubmed/32314081 http://dx.doi.org/10.1007/s10900-020-00821-z |
| _version_ | 1783523800391876608 |
|---|---|
| author | Nusbaum, Neil |
| author_facet | Nusbaum, Neil |
| author_sort | Nusbaum, Neil |
| collection | PubMed |
| description | The COVID-19 pandemic has focused attention on issues of epidemiology, public health, and vaccine design. I submit that attention to COVID-19 pharmacologic therapy needs similar emphasis, including identifying any existing medications that can be repurposed to treat COVID-19 patients. |
| format | Online Article Text |
| id | pubmed-7169637 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71696372020-04-21 Pharmacologic Therapy for COVID-19 Infection Nusbaum, Neil J Community Health Commentary The COVID-19 pandemic has focused attention on issues of epidemiology, public health, and vaccine design. I submit that attention to COVID-19 pharmacologic therapy needs similar emphasis, including identifying any existing medications that can be repurposed to treat COVID-19 patients. Springer US 2020-04-20 2020 /pmc/articles/PMC7169637/ /pubmed/32314081 http://dx.doi.org/10.1007/s10900-020-00821-z Text en © This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Commentary Nusbaum, Neil Pharmacologic Therapy for COVID-19 Infection |
| title | Pharmacologic Therapy for COVID-19 Infection |
| title_full | Pharmacologic Therapy for COVID-19 Infection |
| title_fullStr | Pharmacologic Therapy for COVID-19 Infection |
| title_full_unstemmed | Pharmacologic Therapy for COVID-19 Infection |
| title_short | Pharmacologic Therapy for COVID-19 Infection |
| title_sort | pharmacologic therapy for covid-19 infection |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169637/ https://www.ncbi.nlm.nih.gov/pubmed/32314081 http://dx.doi.org/10.1007/s10900-020-00821-z |
| work_keys_str_mv | AT nusbaumneil pharmacologictherapyforcovid19infection |